These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6237710)
1. The localization of human breast carcinomas by radiolabelled monoclonal antibodies. Rainsbury RM Br J Surg; 1984 Oct; 71(10):805-12. PubMed ID: 6237710 [TBL] [Abstract][Full Text] [Related]
2. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Rainsbury RM; Ott RJ; Westwood JH; Kalirai TS; Coombes RC; McCready VR; Neville AM; Gazet JC Lancet; 1983 Oct; 2(8356):934-8. PubMed ID: 6138503 [TBL] [Abstract][Full Text] [Related]
3. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts. Pimm MV; Perkins AC; Baldwin RW Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340 [TBL] [Abstract][Full Text] [Related]
4. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts. Pimm MV; Perkins AC; Baldwin RW Eur J Nucl Med; 1985; 11(8):300-4. PubMed ID: 4076238 [TBL] [Abstract][Full Text] [Related]
5. The effect of chelating agents on the distribution of monoclonal antibodies in mice. Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701 [TBL] [Abstract][Full Text] [Related]
6. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207 [TBL] [Abstract][Full Text] [Related]
7. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts. Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043 [TBL] [Abstract][Full Text] [Related]
8. Imaging of human ovarian tumour xenografts in nude mice using a novel 111In-labelled monoclonal antibody (10B). Sheldon K; Reilly R; Baumal R; Marks A Int J Rad Appl Instrum B; 1991; 18(5):519-26. PubMed ID: 1917522 [TBL] [Abstract][Full Text] [Related]
9. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690 [TBL] [Abstract][Full Text] [Related]
10. The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy. Perkins AC; Pimm MV; Birch MK Eur J Nucl Med; 1985; 10(7-8):296-301. PubMed ID: 3859410 [TBL] [Abstract][Full Text] [Related]
11. Tumor localization in nude mice bearing human breast carcinoma xenografts using 111In-DTPA conjugates of monoclonal antibodies. Yemul S; Leon JA; Seldin DW; Link MJ; Kramer P; Mesa-Tejada R; Estabrook A Int J Rad Appl Instrum B; 1991; 18(3):295-304. PubMed ID: 2071442 [TBL] [Abstract][Full Text] [Related]
12. Tumour localization using monoclonal antibodies. II. Biodistribution of A5B7/111indium chelates. Barnett P; Buckley RG; Burke PJ; Searle F; Boden JA Int J Cancer Suppl; 1988; 3():34-7. PubMed ID: 3209298 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody LICR-LON-M8 does not predict the outcome of operable breast cancer. Courtemanche DJ; Worth AJ; Coupland RW; Rowell JL; MacFarlane JK Can J Surg; 1991 Feb; 34(1):21-6. PubMed ID: 1847654 [TBL] [Abstract][Full Text] [Related]
14. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. Petrov AD; Narula J; Nakazawa A; Pak KY; Khaw BA Nucl Med Commun; 1997 Mar; 18(3):241-51. PubMed ID: 9106778 [TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors. Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747 [TBL] [Abstract][Full Text] [Related]
16. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and pharmacokinetic characterization of site-specific immunoconjugate 15A8-glycyl-tyrosyl-(N-epsilon-diethylenetriamine pentaacetic acid)-lysine derived from anti-breast carcinoma monoclonal antibody 15A8. Rosenstraus MJ; Davis WL; Lopes AD; D'Aleo CJ; Gilman SC Cancer Res; 1991 Oct; 51(20):5744-51. PubMed ID: 1913693 [TBL] [Abstract][Full Text] [Related]
18. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment]. Stefănescu C; Chossiere L; Rusu V; Meignan M Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458 [TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts. Pimm MV; Baldwin RW Eur J Cancer Clin Oncol; 1984 Apr; 20(4):515-24. PubMed ID: 6586422 [TBL] [Abstract][Full Text] [Related]